Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations. FDA submission planned as five-year pancreatic cancer survival…

Submit Your Paper to GMJ

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

Gambia Trains 25 Community Health Workers in WHO Mental Health Guidelines to Bridge Rural Care Gaps

The Gambia trained 25 community healthcare workers in WHO Mental Health Gap Action Programme guidelines to address critical rural mental…

UK Launches Comprehensive Digital Public Health Resource Hub for Healthcare Professionals

The UK government launches a comprehensive digital platform providing healthcare professionals with centralised access to over 500 evidence-based public health…

WHO Assembly Approves $6.83 Billion Budget to Combat Health Emergencies and AMR

WHO Member States approve $6.83 billion budget for 2026-2027, prioritizing health emergency preparedness and antimicrobial resistance programmes. The budget represents…

Brain Energy Consumption Peaks at 50% in Children, Study Reveals Critical Role of B Vitamins

New research reveals the brain consumes up to 50% of total body energy in 10-year-old children, highlighting the critical role…

Brain Energy Consumption Peaks at 50% in Children, Study Reveals Critical Role of B Vitamins

New research reveals the brain consumes up to 50% of total body energy in 10-year-old children, highlighting the critical role…

Carbohydrate Intake During Exercise Shows Modest Muscle Glycogen Sparing Effects

New meta-analysis of 31 trials reveals carbohydrate intake during prolonged exercise reduces muscle glycogen depletion by 9%. Despite statistical significance,…

Vigorous Exercise Before Stress Blocks Cortisol Surge, Study Shows

New research shows vigorous exercise can reduce cortisol response to psychological stress by up to 42% when performed 45 minutes…

Biogen-Denali Parkinson’s Drug Fails Phase 2 Trial, Highlighting Treatment Development Challenges

Biogen and Denali's experimental Parkinson's therapy failed Phase 2 trial endpoints, highlighting ongoing challenges in neurodegenerative disease drug development. The…

GMJ BriefsView all →